Sailong Pharmaceutical Group Co.,Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 261.14 million compared to CNY 244.05 million a year ago. Revenue was CNY 264.19 million compared to CNY 247.08 million a year ago.

Net loss was CNY 37.31 million compared to CNY 23.34 million a year ago. Basic loss per share from continuing operations was CNY 0.212 compared to CNY 0.1326 a year ago. Diluted loss per share from continuing operations was CNY 0.212 compared to CNY 0.1326 a year ago.